{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:17:15Z","timestamp":1780733835880,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T00:00:00Z","timestamp":1490659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ekir.2017.03.008","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T13:30:27Z","timestamp":1490967027000},"page":"713-720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial"],"prefix":"10.1016","volume":"2","author":[{"given":"Barry I.","family":"Freedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Bates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Chonchol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amret T.","family":"Hawfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Lash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios","family":"Papademetriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Sedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Servilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry M.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Pajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2017.03.008_bib1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ekir.2017.03.008_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"key":"10.1016\/j.ekir.2017.03.008_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ndt\/gfu391","article-title":"APOL1 nephropathy: from gene to mechanisms of kidney injury","volume":"31","author":"Kruzel-Davila","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2017.03.008_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrneph.2015.172","article-title":"Hypertension-attributed nephropathy: what's in a name?","volume":"12","author":"Freedman","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2017.03.008_bib5","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1681\/ASN.2011010069","article-title":"APOL1 localization in normal kidney and nondiabetic kidney disease","volume":"22","author":"Madhavan","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.03.008_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1681\/ASN.2013091017","article-title":"Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines","volume":"26","author":"Ma","year":"2015","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.03.008_bib7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1600-6143.2011.03513.x","article-title":"The APOL1 Gene and Allograft Survival after Kidney Transplantation","volume":"11","author":"Reeves-Daniel","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2017.03.008_bib8","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1600-6143.2012.04033.x","article-title":"The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival","volume":"12","author":"Lee","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2017.03.008_bib9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/TP.0000000000000969","article-title":"APOL1 genotype and kidney transplantation outcomes from deceased African American donors","volume":"100","author":"Freedman","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2017.03.008_bib10","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1681\/ASN.2013070700","article-title":"Plasma apolipoprotein L1 levels do not correlate with CKD","volume":"25","author":"Bruggeman","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.03.008_bib11","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1194\/jlr.M063453","article-title":"Characterization of circulating APOL1 protein complexes in African Americans","volume":"57","author":"Weckerle","year":"2016","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.ekir.2017.03.008_bib12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.03.008_bib13","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.2215\/CJN.01330214","article-title":"Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy","volume":"9","author":"Freedman","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.03.008_bib14","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1073\/pnas.1522913113","article-title":"APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases","volume":"113","author":"Olabisi","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ekir.2017.03.008_bib15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1681\/ASN.2016050567","article-title":"APOL1 renal-risk variants induce mitochondrial dysfunction","volume":"28","author":"Ma","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.03.008_bib16","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ndt\/gfv229","article-title":"APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans","volume":"31","author":"Gutierrez","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2017.03.008_bib17","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCRESAHA.114.302347","article-title":"Increased burden of cardiovascular disease in carriers of APOL1 genetic variants","volume":"114","author":"Ito","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.ekir.2017.03.008_bib18","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/ATVBAHA.115.305970","article-title":"APOL1 Genotype, kidney and cardiovascular disease, and death in older adults","volume":"36","author":"Mukamal","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ekir.2017.03.008_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ki.2014.255","article-title":"APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes","volume":"87","author":"Freedman","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.03.008_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/ki.2014.254","article-title":"Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial","volume":"87","author":"Langefeld","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.03.008_bib21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.kint.2016.02.032","article-title":"APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease","volume":"90","author":"Ma","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.03.008_bib22","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.kint.2016.04.027","article-title":"APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume","volume":"90","author":"Freedman","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.03.008_bib23","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1681\/ASN.2015070763","article-title":"Race, APOL1 risk, and eGFR decline in the general population","volume":"27","author":"Grams","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2017.03.008_bib24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.kint.2016.09.033","article-title":"Strict blood pressure control and mortality risk by APOL1 genotype","volume":"91","author":"Ku","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2017.03.008_bib25","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2017.03.008_bib26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1177\/1740774514537404","article-title":"The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT)","volume":"11","author":"Ambrosius","year":"2014","journal-title":"Clin Trials"},{"key":"10.1016\/j.ekir.2017.03.008_bib27","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2017.03.008_bib28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S0197-2456(00)00104-5","article-title":"Sample-size calculations for the Cox proportional hazards regression model with nonbinary covariates","volume":"21","author":"Hsieh","year":"2000","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ekir.2017.03.008_bib29","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa072100","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups","volume":"358","author":"Detrano","year":"2008","journal-title":"N\u00a0Engl J Med"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024917300621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024917300621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T09:20:22Z","timestamp":1568971222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024917300621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2468024917300621"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2017.03.008","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"APOL1 Renal-Risk Variants Do Not Associate With Incident Cardiovascular Disease or Mortality in the Systolic Blood Pressure Intervention Trial","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2017.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017, International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}